BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, February 21, 2026
Home » Authors » Karen Carey

Articles by Karen Carey

Passion, achievement, need in 30 seconds: The art of the pitch

June 17, 2015
By Karen Carey
PHILADELPHIA – Capturing the attention of potential investors in 30 seconds or less poses a challenge for even the most sophisticated wordsmiths when attempting to describe complicated technologies and commercial potential.
Read More

#PCTUS explores roles of China, India in global clinical development

April 29, 2015
By Karen Carey
BOSTON – Shorter timelines to market and larger patient pools serve as major incentives for companies to bring clinical development work to China and India, although regulatory and cultural differences remain a hurdle. In its 24th year, the Partnerships in Clinical Trials conference started Wednesday.
Read More

The consumerization of healthcare: More digital, more personal experience

April 27, 2015
By Karen Carey

Data transparency and social media: Challenges, opportunity converge

April 27, 2015
By Karen Carey
BOSTON – Conducting clinical trials is a tricky business, especially when making data transparent for researchers while still protecting intellectual property, and when offering potential life-saving but not fully understood or reimbursed therapies to dying patients on a compassionate basis.
Read More

The consumerization of health care: More digital, more personal

April 24, 2015
By Karen Carey
BOSTON – Gone are the days of expensive diagnostics and lengthy clinical trials, as interest and enthusiasm over digital medicine and personalized medicine are shifting the attitudes and expectations of drug developers and insurance companies, as well as consumers themselves.
Read More

#PCTUS explores roles of China, India in global clinical development

April 23, 2015
By Karen Carey
BOSTON – Shorter timelines to market and larger patient pools serve as major incentives for companies to bring clinical development work to China and India, although regulatory and cultural differences remain a hurdle.
Read More

JOBS Act two years later, biotech IPOs nearly tripled

Oct. 13, 2014
By Karen Carey
SAN FRANCISCO – Since the April 2012 passage of the Jumpstart Our Business Startup (JOBS) Act, the rate of new biotech initial public offerings (IPOs) has nearly tripled, with 115 since enactment, and about 65 this year.
Read More

Gene therapy advances beyond first era setbacks, but challenges remain

Oct. 9, 2014
By Karen Carey
SAN FRANCISCO – The 2012 European approval of Uniqure BV's Glybera has sparked a renewal of interest in gene therapy, a field that was marred by a serious setback in 1999 that proved fatal for a patient.
Read More

Manufacturing, specificity challenges, also enormous potential for T-cell therapies

Oct. 8, 2014
By Karen Carey
SAN FRANCISCO – Displaying two radiographs side by side on a screen, Kite Pharma Inc.'s chief medical officer, David Chang, illustrated the profound potential of T-cell therapies in treating advanced cancers.
Read More

Tekmira tackling Ebola: Addressing regulatory, investor expectations, patient needs

Oct. 8, 2014
By Karen Carey
SAN FRANCISCO – Attendees of the 13th BIO Investor Forum held at the Palace Hotel here crowded into the Twin Peaks meeting room to eat their boxed lunches on Tuesday as they listened to one company's accelerated response to the Ebola virus outbreak.
Read More
Previous 1 2 … 86 87 88 89 90 91 92 93 94 … 161 162 Next

Popular Stories

  • Today's news in brief

    BioWorld
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • Illustration of head with maze that is missing parts

    Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

    BioWorld Science
    Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
  • Illustration of brain and antibodies

    VST Bio’s VB-001 is neuroprotector after stroke

    BioWorld Science
    At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing